Bonness Enterprises’s Pfizer PFE Stock Holding History

Bonness Enterprises’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.29M	Buy	178,308 +800	+0.5%	+$20.9K	1.38%	16
2026 Q1	$4.98M	Buy	177,508 +16,000	+10%	+$426K	1.82%	13
2025 Q4	$4.02M	Hold	161,508	–	–	1.39%	17
2025 Q3	$4.12M	Hold	161,508	–	–	1.35%	17
2025 Q2	$3.91M	Hold	161,508	–	–	1.28%	17
2025 Q1	$4.09M	Hold	161,508	–	–	1.34%	15
2024 Q4	$4.28M	Buy	161,508 +5,300	+3%	+$144K	1.5%	15
2024 Q3	$4.52M	Buy	156,208 +5,600	+4%	+$163K	1.5%	15
2024 Q2	$4.21M	Buy	150,608 +35,900	+31%	+$988K	1.54%	15
2024 Q1	$3.18M	Hold	114,708	–	–	1.15%	18
2023 Q4	$3.3M	Buy	114,708 +5,000	+5%	+$151K	1.38%	18
2023 Q3	$3.64M	Hold	109,708	–	–	1.67%	17
2023 Q2	$4.02M	Buy	109,708 +23,100	+27%	+$899K	1.81%	14
2023 Q1	$3.53M	Hold	86,608	–	–	1.57%	18
2022 Q4	$4.44M	Hold	86,608	–	–	2.09%	9
2022 Q3	$3.79M	Hold	86,608	–	–	2.02%	11
2022 Q2	$4.54M	Hold	86,608	–	–	2.27%	9
2022 Q1	$4.48M	Buy	86,608 +5,400	+7%	+$280K	2.06%	11
2021 Q4	$4.79M	Buy	81,208 +2,600	+3%	+$129K	2.21%	12
2021 Q3	$3.38M	Hold	78,608	–	–	1.72%	18
2021 Q2	$3.08M	Hold	78,608	–	–	1.55%	20
2021 Q1	$2.85M	Hold	78,608	–	–	1.52%	19
2020 Q4	$2.89M	Sell	78,608 -4,245	-5%	-$156K	1.62%	17
2020 Q3	$2.88M	Hold	82,853	–	–	1.7%	17
2020 Q2	$2.57M	Hold	82,853	–	–	1.65%	17
2020 Q1	$2.57M	Hold	82,853	–	–	1.85%	15
2019 Q4	$3.08M	Hold	82,853	–	–	1.94%	15
2019 Q3	$2.82M	Hold	82,853	–	–	1.81%	13
2019 Q2	$3.4M	Hold	82,853	–	–	2.13%	10
2019 Q1	$3.34M	Hold	82,853	–	–	2.17%	11
2018 Q4	$3.43M	Hold	82,853	–	–	2.58%	10
2018 Q3	$3.46M	Hold	82,853	–	–	2.27%	10
2018 Q2	$2.85M	Hold	82,853	–	–	2.02%	15
2018 Q1	$2.79M	Hold	82,853	–	–	1.94%	14
2017 Q4	$2.85M	Hold	82,853	–	–	1.93%	16
2017 Q3	$2.81M	Hold	82,853	–	–	2.01%	14
2017 Q2	$2.64M	Hold	82,853	–	–	2.02%	14
2017 Q1	$2.69M	Hold	82,853	–	–	2.15%	14
2016 Q4	$2.55M	Sell	82,853 -5,270	-6%	-$161K	2.29%	13
2016 Q3	$2.83M	Hold	88,123	–	–	2.35%	13
2016 Q2	$2.94M	Hold	88,123	–	–	2.47%	12
2016 Q1	$2.48M	Hold	88,123	–	–	2.13%	14
2015 Q4	$2.7M	Hold	88,123	–	–	2.43%	12
2015 Q3	$2.63M	Hold	88,123	–	–	2.51%	10
2015 Q2	$2.8M	Hold	88,123	–	–	2.53%	12
2015 Q1	$2.91M	Hold	88,123	–	–	2.58%	11
2014 Q4	$2.6M	Sell	88,123 -1,054	-1%	-$30.2K	2.25%	14
2014 Q3	$2.5M	Hold	89,177	–	–	2.25%	14
2014 Q2	$2.51M	Sell	89,177 -7,378	-8%	-$210K	2.28%	14
2014 Q1	$2.94M	Hold	96,555	–	–	2.59%	11
2013 Q4	$2.81M	Hold	96,555	–	–	2.48%	11
2013 Q3	$2.63M	Hold	96,555	–	–	2.53%	11
2013 Q2	$2.57M	Buy	+96,555	New	+$2.67M	2.54%	12

Other funds holding PFE

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Bonness Enterprises's PFE Position: Q2 2026 in Review

Bonness Enterprises increased its Pfizer (PFE) stake by 0.45% in Q2 2026, buying an estimated $20.9K and bringing the position to 178,308 shares worth $4.29M. The position accounts for 1.38% of the portfolio, ranked #16.

Bonness Enterprises first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.98M in Q1 2026. 1,369 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bonness Enterprises held 178,308 shares of Pfizer worth $4.29M as of Q2 2026.
Bonness Enterprises bought 800 Pfizer shares in Q2 2026, an estimated $20.9K.
Pfizer made up 1.38% of Bonness Enterprises's portfolio in Q2 2026, its #16 holding.
Bonness Enterprises first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Bonness Enterprises's Pfizer position peaked at $4.98M in Q1 2026.
1,369 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bonness Enterprises's 13F filing for Q2 2026, filed 9 Jul 2026.